Pathogenic variants in FGFR1 and KLB have individually been described in the setting of Kallman syndrome, a disorder characterized by hypogonadotropic hypogonadism and loss of smell (anosmia). This evidence concerns the gene FGFR1 and hypogonadotropic hypogonadism.